PRME
PRIME MEDICINE (PRME)
NASDAQ
$3.22-$0.16 (-4.60%)
Price as of Jun 23, 2026 7:28 PM EDT
  • $608.7M
    Market Cap
  • 56.02%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
4.6M
+53.74%
3.0M
N/A
N/A
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
4.6M
+53.74%
3.0M
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-160.6M
+3.44%
-155.3M
+4.99%
-147.9M
+70.54%
-86.7M
N/A
Depreciation and Amortization Expense
7.3M
+19.47%
6.1M
+31.70%
4.7M
+109.22%
2.2M
N/A
Total Operating Expenses
213.0M
+3.67%
205.4M
+0.32%
204.8M
+75.72%
116.5M
N/A
Operating Profit
-208.3M
+2.91%
-202.5M
-1.14%
-204.8M
+75.72%
-116.5M
N/A
Interest Income
4.1M
+17.80%
3.5M
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
4.1M
+17.80%
3.5M
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
7.2M
+9.46%
6.6M
+3.21%
6.4M
+202.49%
-6.2M
N/A
Income before Taxes
-201.1M
+2.69%
-195.9M
-1.28%
-198.4M
+61.61%
-122.8M
N/A
Income Taxes
0
N/A
0
+100.00%
-279,000
-70.57%
-948,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-201.1M
+2.69%
-195.9M
-1.14%
-198.1M
+62.64%
-121.8M
N/A
Net Income from Continuing Operations Applicable to Common
-201.1M
+2.69%
-195.9M
-1.14%
-198.1M
+39.52%
-142.0M
N/A
Basic EPS and Net Income
-1.35
-18.18%
-1.65
-24.31%
-2.18
-47.97%
-4.19
N/A
Diluted EPS and Net Income
-1.35
-18.18%
-1.65
-24.31%
-2.18
-47.97%
-4.19
N/A
Basic Weighted Average Shares
148.8M
+25.43%
118.6M
+30.37%
91.0M
+168.42%
33.9M
N/A
Diluted Weighted Average Shares
148.8M
+25.43%
118.6M
+30.37%
91.0M
+168.42%
33.9M
N/A
Balance Sheet
Cash and Cash Equivalents
63.0M
-65.46%
182.5M
+338.92%
41.6M
-77.84%
187.6M
N/A
Short-Term Investments
114.6M
+1,339.22%
8.0M
-90.05%
80.1M
-18.66%
98.5M
N/A
Cash and Cash Equivalents and Short-Term Investments
177.7M
-6.70%
190.4M
+56.53%
121.7M
-57.47%
286.1M
N/A
Total Current Assets
181.3M
-14.44%
211.9M
+48.20%
143.0M
-51.80%
296.6M
N/A
Accumulated Depreciation
20.4M
+50.28%
13.6M
+81.68%
7.5M
+164.36%
2.8M
N/A
Property and Plant and Equipment and Net
20.6M
-15.70%
24.4M
+7.70%
22.7M
+19.20%
19.0M
N/A
Total Long-Term Assets
1.0M
N/A
0
-100.00%
779,000
-52.67%
1.6M
N/A
Total Assets
342.7M
+15.20%
297.5M
+53.47%
193.9M
-46.20%
360.3M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
0
-100.00%
279,000
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
37.4M
-1.35%
38.0M
-32.72%
56.4M
+111.21%
26.7M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
166.4M
+65.76%
100.4M
+2,204.29%
4.4M
-75.26%
17.6M
N/A
Total Liabilities
221.9M
+53.69%
144.4M
+137.51%
60.8M
+38.00%
44.0M
N/A
Retained Earnings
-888.4M
+29.27%
-687.2M
+39.87%
-491.3M
+67.58%
-293.2M
N/A
Total Stockholders Equity
120.9M
-21.08%
153.1M
+15.09%
133.1M
-57.92%
316.3M
N/A
Total Shares Outstanding
180.5M
+37.63%
131.2M
+34.69%
97.4M
+0.17%
97.2M
N/A
Cash Flow
Cash from Operating Activities
-162.6M
+32.31%
-122.9M
-25.72%
-165.4M
+25.48%
-131.8M
N/A
Capital Expenditures
4.5M
-37.88%
7.3M
-16.39%
8.7M
-45.80%
16.1M
N/A
Cash from Investing Activities
-108.8M
-258.88%
68.5M
+265.86%
18.7M
+139.73%
-47.1M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
151.5M
-22.65%
195.9M
+29,804.73%
655,000
-99.64%
181.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-4,543.17%
-33.06%
-6,787.36%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-62.83%
-21.19%
-79.73%
+11.50%
-71.51%
N/A
N/A
N/A
Return on Equity
-146.81%
+7.26%
-136.88%
+55.21%
-88.19%
N/A
N/A
N/A
Revenue Growth
53.74%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
4.84
-13.27%
5.58
+120.27%
2.53
N/A
N/A
N/A
Cash Ratio
1.68
-64.98%
4.81
+552.40%
0.74
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow